We found that the high impact mutations in JMJD1C, SLA, PDZD2, identified from in-silico analysis in PTC samples, are missing in the thyroid cancer cell lines analyzed, thus suggesting that the altered expression of these genes is due to other regulative biological mechanisms. The gene discussed is SLA; the disease is thyroid cancer.